A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients - Archive ouverte HAL Access content directly
Journal Articles Clinical Cancer Research Year : 2016

A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients

(1) , (2) , (3) , (1, 4) , (1, 4) , (4) , (5) , (5) , (4) , (6) , (7) , (8, 9) , (2) , (10) , (1) , (2) , (1, 4) , (1)
1
2
3
4
5
6
7
8
9
10
Alexandre Aussem
Haytham Elghazel
Michel Attal
  • Function : Author
  • PersonId : 944589

Abstract

Purpose: Painful peripheral neuropathy is a frequent toxicity associated with bortezomib therapy. This study aimed to identify loci that affect susceptibility to this toxicity. Experimental Design: A genome-wide association study (GWAS) of 370,605 SNPs was performed to identify risk variants for developing severe bortezomib-induced peripheral neuropathy (BiPN) in 469 multiple myeloma (MM) patients who received bortezomib-dexamethasone therapy prior to autologous stem-cell in randomized clinical trials of the Intergroupe Francophone du Myelome (IFM) and findings were replicated in 114 MM patients of the HOVON-65/GMMG-HD4 clinical trial. Results: A single SNP in the PKNOX1 gene was associated with BiPN in the exploratory cohort (rs2839629; OR, 1.89, 95% CI: [1.45-2.44]; P = 7.6 x 10-6) and in the replication cohort (OR, 2.04; 95% CI = [1.11-3.33]; P= 8.3 x 10-3). In addition, rs2839629 is in strong linkage disequilibrium (r2 = 0.87) with rs915854, located in the intergenic region between PKNOX1 and CBS . Expression quantitative trait loci mapping showed that both rs2839629 and rs915854 genotypes impact PKNOX1 expression in nerve tissue while rs2839629 affects CBS expression in skin and blood. Conclusions: The use of GWAS in MM pharmacogenomics has identified a novel candidate genetic locus mapping to PKNOX1 and in the immediate vicinity of CBS at 21q22.3 associated with the severe bortezomib-induced toxicity. The proximity of these two genes involved in neurologic pain whose tissue-specific expression is modified by the two variants provides new targets for neuroprotective strategies.
Fichier principal
Vignette du fichier
Clin Cancer Res-2016-Magrangeas-1078-0432.CCR-15-3163.pdf (476.38 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

inserm-01313506 , version 1 (10-05-2016)

Identifiers

Cite

Florence Magrangeas, Rowan Kuiper, Hervé Avet-Loiseau, Wilfried Gouraud, Catherine Guérin-Charbonnel, et al.. A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients: GWAS in multiple myeloma pharmacogenomics. Clinical Cancer Research, 2016, Epub ahead of print. ⟨10.1158/1078-0432.CCR-15-3163⟩. ⟨inserm-01313506⟩
916 View
282 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More